BioMedWire
BioMedWire is a privately held B2B digital newswire and corporate communications service that distributes press releases, earnings, and editorial content for publicly traded and pre-IPO life sciences issuers to investors, traders, journalists, and fund managers.
- Company typePrivate
- Founded-
- HeadquartersAustin, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BioMedWire does
BioMedWire (BMW) is a privately held B2B digital newswire and corporate communications service headquartered in Austin, Texas and incorporated in Delaware. It distributes corporate news, press releases, earnings statements, and branded editorial content on behalf of publicly traded and pre-IPO life sciences issuers—biotechnology, pharmaceutical, biomedical device, and nutraceutical companies—targeting retail and institutional investors, day traders, financial journalists, and fund managers. The company operates as one of more than 50 brands within the InvestorBrandNetwork (IBN) ecosystem and is positioned against incumbent wire services such as BusinessWire (a Berkshire Hathaway subsidiary) and PR Newswire (a Cision subsidiary), competing on sector specialization and the breadth of the bundled IBN stack.
The product portfolio is anchored by the IBNAi-powered digital newswire and content syndication engine and includes the tiered Brand Awareness Distribution (BAD) suite (Professional, Bulk, and Agency Bulk packages), Press Release Enhancement, Social Media Solutions, full-stack Corporate Communications covering investor relations, public relations, video production, and web services, plus the audio products AudioPressRelease (APR) and NetworkNewsAudio. Distribution scales through 5,000+ outlets spanning 55+ countries domestically and internationally, with the IBN network contributing a 2+ million social follower audience for amplification.
Revenue is generated through direct sales of tiered BAD packages priced on 5-day, 12-24 day, and 36-48+ day windows, plus multi-year subscription-style client-partner agreements sold on non-cancelable, non-refundable terms. Approximately 300+ companies have used BMW's tools cumulatively. The company also accepts cryptocurrency payments (Bitcoin, Ethereum, USDC), broadening its addressable buyer pool to digital-asset-native biotech issuers. No outside investors or funding events are disclosed, and the business operates as a privately held services firm within the broader IBN umbrella rather than as an independent venture-backed platform.
BioMedWire firmographics
Firmographics- Name
- BioMedWire
- Legal name
- BioMedWire
- Website
- https://biomedwire.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioMedWire is a privately held B2B digital newswire and corporate communications service that distributes press releases, earnings, and editorial content for publicly traded and pre-IPO life sciences issuers to investors, traders, journalists, and fund managers.
- Ownership category
- akta.pro rank
BioMedWire industry classification
Industry- Product category
- Newswire and Corporate Communications Services
- NAICS
- Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (516210)
- akta.pro primary industry
- Healthcare & Life Sciences PR (MPAAADAD)
Keywords
Where BioMedWire is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioMedWire business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Press Release Distribution Services: BioMedWire receives cash compensation from companies (in the form of cash, check, credit card, and wire payments) for disseminating advertising, marketing news distribution, and public relations solutions on their behalf. Companies pay fees for press release enhancement, syndication, and distribution services.
- Brand Awareness Solutions: Fees for brand awareness campaigns, corporate communications, and marketing services. The GTSA indicates payment obligations are non-cancelable with fees paid being non-refundable, suggesting recurring subscription-type revenue from ongoing client-partner relationships.
- Client-Partner Services: Comprehensive suite of communications tools including Brand Awareness, Corporate Communications, Syndicated Communications, Press Release Enhancement, and Social Media Solutions delivered under subscription agreements with tiered campaign options (BAD Professional, BAD Bulk, BAD Agency Bulk).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | BAD Professional Campaign - 5 days of continuous North American coverage with multi-ticker tagged editorial articles and amplified traffic generation |
| Subscription | Multi-year contract | BAD Bulk Campaign - 12-24 days of branded coverage with multiple syndicated editorial articles |
| Subscription | Multi-year contract | BAD Agency Bulk Campaign - 36-48+ days of coverage for multiple public companies |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels8 records
BioMedWire product offering
Product offeringCore offering
BioMedWire is a newswire and publishing service within the InvestorBrandNetwork (IBN) ecosystem that distributes corporate news, press releases, and editorial content for medical, biotechnology, and life sciences companies. It packages press release syndication, editorial coverage, and social media amplification for paying issuer clients, syndicating content through a network of 5,000+ media outlets, financial portals, and downstream channels.
Product overview
BioMedWire (BMW) is a technology-driven digital news and publishing platform for the medical and biotechnology sector, operating as part of the InvestorBrandNetwork (IBN). The core offering is the BioMedWire newswire service, which provides syndicated communications across 5,000+ distribution outlets. The platform operates on a modular architecture comprising: core BioMedWire news aggregation and syndication; Brand Awareness Distribution (BAD) for ticker-tagged editorial syndication and digital traffic generation; Press Release Enhancement for editorial quality; Social Media Solutions for multi-platform amplification; Corporate Communications including investor relations and public relations services; and Video Production capabilities. Add-on modules include AudioPressRelease (APR) and NetworkNewsAudio podcast distribution, website development, and the Client-Partner program providing extended coverage features.
Differentiator
Problem solved
Functional benefit
Products and services
- BioMedWire Press Release Distribution Wire-format press release distribution service for publicly traded and emerging biotech, pharmaceutical, and life sciences companies, syndicating corporate news across a network of 5,000+ media outlets, financial portals, and downstream channels. Targeted at IR and corporate communications buyers at life sciences issuers.
- BioMedWire Editorial Coverage Editorial-authored and editorial-reviewed content pieces published and syndicated for life sciences clients to support investor awareness campaigns, conference coverage, and corporate milestone announcements. Targeted at biotech and life sciences issuers needing third-party credibility.
- BioMedWire Social Media and RSS Amplification Social media channel and RSS feed distribution of client corporate news to expand reach beyond traditional wire endpoints, integrated with BioMedWire's syndication workflow. Targeted at IR and corporate communications teams seeking broader retail-investor and social reach.
- InvestorBrandNetwork (IBN) Integrated Communications Bundle Combined communications and distribution offering spanning BioMedWire's life-sciences-specialized services together with other IBN vertical wires, providing multi-sector editorial, syndication, and investor relations support to publicly traded issuers. Targeted at issuers needing multi-vertical communications coverage under one vendor relationship.
Quantifiable outcome
- Reaches millions of investors through 5,000+ distribution outlets
- +1 more outcomes
Companies that use BioMedWire
Customer profileSegments4 records
Ideal customer profiles1 record
BioMedWire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability3 records
Feature5 records
BioMedWire partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core and minor.
- Yahoo FinancecoreMajor financial portal for news distribution, providing exposure to retail investors and financial professionals through news syndication.
- MarketWatchcoreTier-one financial news destination for ticker-tagged editorial syndication and press release distribution.
- ReuterscoreInternational financial news agency for global distribution of branded content.
- CNBCcoreBroadcast financial media partner for digital news portal distribution and financial content syndication.
- BenzingacoreFinancial news and media outlet for digital traffic generation and investor visibility.
- E*TRADEcoreBrokerage platform for financial news distribution to active investors and traders.
- TD AmeritradecoreBrokerage terminal partner for news and press release syndication to investor demographics.
- The Wall Street Journal (WSJ)coreMajor financial newspaper and news portal for premium news syndication and investor reach.
- Barron'scoreFinancial publication partner for news distribution and editorial syndication.
- GlobeNewswirecorePress release wire service partner for additional coverage via IW North American Plus distribution.
- BarchartcoreFinancial data and charting platform for ticker-tagged editorial syndication targeting investors.
- BloombergcoreFinancial terminal and news service for comprehensive news distribution to institutional and retail investors.
- InvestorBrandNetwork (IBN)coreParent/organizational network providing 50+ trusted brands and 2+ million social media followers for Core Client Partner Coverage. BioMedWire is powered by IBN.
- BIO InformaminorConference and event partner for biotech/life sciences industry visibility.
- DGE Dynamic Global EventsminorHealthcare conference partner for event marketing and industry visibility.
- DTC Healthcare ConferenceminorHealthcare-focused conference partner for event marketing and industry exposure.
- Kiasco ResearchminorResearch and market intelligence partner for life sciences sector coverage.
- Nexus ConferencesminorConference partner for industry event presence and networking opportunities.
- OctaneminorConference and events partner for life sciences and healthcare industry visibility.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
BioMedWire competitors and assessment
Company assessmentBroad incumbents
- Cision: Parent company of PR Newswire and Marketwired; broader incumbent in PR software, media monitoring, and communications workflow. Operates as an established incumbent in BioMedWire's category with a much wider product portfolio.
Emerging players
- iCrowdNewswire: Smaller, newer digital press release distribution service focused on affordable wire distribution for SMBs. Partial overlap with BioMedWire's pay-as-you-go positioning for smaller issuers.
- IssueWire: Affordable digital press release distribution service targeting small businesses and startups. Comparable low-cost distribution offering versus BioMedWire's no-contract positioning.
Direct peers
- ACCESSWIRE: Press release distribution service focused on small and mid-cap public companies. Closely comparable business model to BioMedWire, particularly in target client segment.
- EIN Presswire: Press release distribution service with broad wire and SEO syndication across news networks and financial sites. Directly comparable service offering for small/mid-cap public company communications.
- GlobeNewswire: Press release distribution service owned by Notified (formerly part of Intrado). BioMedWire explicitly lists GlobeNewswire as a direct competitor in its own comparison marketing material.
- PR Newswire (Cision): Major press release distribution service owned by Cision, serving public companies and PR agencies with wire distribution and media monitoring. Direct competitor in the same wire distribution category.
- 24-7 Press Release Newswire: Press release distribution service offering wire, SEO, and social media distribution to a similar SMB and small-cap public company client base. Comparable offering scope and pricing tier.
- Business Wire: Largest direct competitor in press release wire distribution, owned by Berkshire Hathaway. Serves similar B2B communications clients with comparable wire, social, and financial portal syndication; BioMedWire explicitly compares against it as a benchmark.
- InvestorWire: Sibling brand within the same InvestorBrandNetwork (IBN) ecosystem. Operates the same wire distribution / syndication model with the same parent infrastructure but targets the broader investor market rather than life sciences specifically.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BioMedWire social profiles
Digital presenceBioMedWire financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioMedWire leadership team
Management profileNumber of profiles
Profiles1 record
BioMedWire funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioMedWire M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioMedWire
What does BioMedWire do?
BioMedWire is a newswire and publishing service within the InvestorBrandNetwork (IBN) ecosystem that distributes corporate news, press releases, and editorial content for medical, biotechnology, and life sciences companies. It packages press release syndication, editorial coverage, and social media amplification for paying issuer clients, syndicating content through a network of 5,000+ media outlets, financial portals, and downstream channels.
Is BioMedWire a public or private company?
BioMedWire is a private company. It is classified as corporate owned and is currently operating.
When was BioMedWire founded?
BioMedWire was founded in -1. It employs 1 to 10 people.
Where is BioMedWire based?
BioMedWire is headquartered in Austin, United States, in the North America region.
How does BioMedWire make money?
Three revenue lines are on record. Press Release Distribution Services are the primary driver. The others are brand Awareness Solutions and client-Partner Services.
Who are BioMedWire's main competitors?
Cision is listed as a broad incumbent. Emerging players are iCrowdNewswire and IssueWire. Direct peers are ACCESSWIRE, EIN Presswire, GlobeNewswire, PR Newswire (Cision), 24-7 Press Release Newswire, Business Wire and InvestorWire.
Does BioMedWire have an API?
No public API is recorded for BioMedWire.
What industry is BioMedWire in?
BioMedWire's product category is Newswire and Corporate Communications Services. Its primary akta.pro industry code is MPAAADAD, Healthcare & Life Sciences PR. Its NAICS code is 516210.